Mendoza, Abdel Azis .
HRN: 21-47-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2023
CEFUROXIME 750MG (VIAL)
06/18/2023
06/25/2023
IV
260mg
Q8
Sepsis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes